Peptide LocalCompare price, evidence & access
Search /Compare vendors
Locations/United States/CagriSema
Purchase and availability checkCagriSema in the United States

Can you buy CagriSema in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. CagriSema is an investigational clinical program.

Direct answers →Open official records →Open the interactive status check
Evidence lane
Investigational clinical program
Destination
United States
Source records
3
Reviewed
July 24, 2026
ByPeptide Local Editorial DeskUpdated July 24, 2026How we review
Direct answers

What this exact search can and cannot establish.

Each answer stays attached to the compound identity and destination records. This is a verification guide, not medical or legal advice, a seller recommendation, or proof of availability.

01

Can you buy CagriSema in the United States?

This page does not establish a legitimate retail purchase from the compound name or an online listing alone. CagriSema is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below. Before acting on an offer, match the exact product, authorization, seller identity, and supply route in the official records below.

02

Which official records should be checked for CagriSema in United States?

Resolve the exact identity of CagriSema through REDEFINE 1 Phase 3 study - NCT05567796 from ClinicalTrials.gov. Then search Drugs@FDA approved drug database from U.S. Food and Drug Administration for the destination product record and Locate a state-licensed online pharmacy from U.S. Food and Drug Administration for the seller, establishment, or supply route in United States. A match in one record does not replace the other two checks.

03

Does an online listing prove CagriSema is authorized or available in United States?

No. A page using the name CagriSema, local currency, a domestic delivery claim, or a familiar package image is only a lead. This is an investigational program, not an approved product for sale. A seller listing cannot inherit the sponsor's clinical identity, trial evidence, or regulatory status. For United States, the exact product, presentation, seller identity, current record status, and claimed supply route must resolve through the official sources on this page.

Live trial footprint

CagriSema clinical trials in United States

22 study records currently list 906 locations in this country, including 106 locations individually marked Recruiting.

Registry update: July 24, 2026
Study records
22
Listed locations
906
Recruiting locations
106
Records with local recruiting sites
3
NCT07253285
Study-wide statusRecruiting

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Listed locations
34
Recruiting locations
10
Registry update
2026-07-17
NCT07564414
Study-wide statusRecruiting

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Listed locations
99
Recruiting locations
94
Registry update
2026-07-08
NCT07184086
Study-wide statusRecruiting

A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to Diet

Listed locations
2
Recruiting locations
2
Registry update
2025-10-08
NCT07011667
Study-wide statusActive, not recruiting

A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term

Listed locations
46
Recruiting locations
0
Registry update
2026-07-24
NCT05567796
Study-wide statusActive, not recruiting

A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose Weight

Listed locations
46
Recruiting locations
0
Registry update
2026-07-17
NCT05669755
Study-wide statusActive, not recruiting

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

Listed locations
119
Recruiting locations
0
Registry update
2026-07-17
Continue the exact comparison

Related country and compound records.

Compare another tracked name in United States, or keep CagriSema fixed and change the destination within North America. The identity, product, and seller checks remain separate.

Continue the exact comparison

CagriSema in North America

CagriSema across 42 countries
Identity before availability

A name alone cannot establish a local verdict.

CagriSema is an investigational clinical program. No seller listing in the United States can inherit the sponsor’s clinical identity, trial evidence, or regulatory status. Check any exact product and supplier claim in the destination records below.

Primary identity source: REDEFINE 1 Phase 3 study - NCT05567796 / ClinicalTrials.gov ↗
Three-record verification path

Identity. Product. Seller or supply.

A credible result must keep these separate. The official links answer different questions and should be checked in sequence.

REDEFINE 1 Phase 3 study - NCT05567796

REDEFINE 1 Phase 3 study - NCT05567796 is maintained by ClinicalTrials.gov. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open REDEFINE 1 Phase 3 study - NCT05567796 ↗

Drugs@FDA approved drug database

Drugs@FDA approved drug database is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Drugs@FDA approved drug database ↗

Locate a state-licensed online pharmacy

Locate a state-licensed online pharmacy is maintained by U.S. Food and Drug Administration. Open the current record and match the exact name, holder, presentation, legal entity, status, or route relevant to the claim.

Open Locate a state-licensed online pharmacy ↗
United States / Country guide

United States market context.

A US peptide search can surface prescription drugs, compounded preparations, telehealth offers, and laboratory-research materials in one result set. Federal and state records answer different questions, so no single lookup validates every route.

  • FDA’s BeSafeRx directory sends consumers to each state board’s pharmacy-license database and says an unlisted online pharmacy should not be used.
  • Sections 503A and 503B apply different conditions to compounding from bulk drug substances; FDA updates the underlying lists and policies as substances are evaluated.
  • FDA’s peptide-related bulk-substance page identifies limited information or potential safety concerns for several names that also appear in research and wellness marketing.
Destination checklist

Repeat the country checks before comparing any offer.

The country guide supplies the local verification sequence. It does not convert an online listing into an authorized product or verified seller.

01

Start with the seller class

For an online pharmacy claim, use FDA’s state-license directory to reach the relevant board database and match the business, address, and current license before comparing price.

02

Separate the federal record

Check FDA approval, shortage, outsourcing-facility, and bulk-substance records separately; a state pharmacy license does not make every product or compounding claim federally supported.

03

Keep research outside care

A laboratory-research listing is not a prescription pathway. Compare only like-for-like catalog rows and retain the research-only boundary, source date, shipping claim, and evidence-access label.

Primary evidence

Audit every source used by this page.

Open the live record and confirm its current status. A linked source begins the verification process; it does not mean Peptide Local authenticated a product or seller.

01
NCT05567796: A Research Study to See How Well CagriSema Helps People With Excess Body Weight Lose WeightClinicalTrials.gov
02
Drugs@FDA approved drug databaseU.S. Food and Drug Administration
03
Locate a state-licensed online pharmacyU.S. Food and Drug Administration
04
Bulk drug substances used in compoundingU.S. Food and Drug Administration
05
Peptide and other bulk-substance safety risksU.S. Food and Drug Administration
06
CagriSema study search in United StatesClinicalTrials.gov
07
NCT07253285: A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body WeightClinicalTrials.gov
08
NCT07564414: A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose WeightClinicalTrials.gov
09
NCT07184086: A Study to See How Metabolism is Influenced by Weight Loss Due to Intervention With Cagrilintide and Semaglutide Compared to DietClinicalTrials.gov
10
NCT07011667: A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-termClinicalTrials.gov
11
NCT05669755: REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood VesselsClinicalTrials.gov
Audit and handoff

Keep the exact record attached.